Bausch & Lomb Incorporated Market Share Analysis

Summary

GlobalData’s new report, “Bausch & Lomb Incorporated Market Share Analysis” provides in-depth information on Bausch & Lomb Incorporated’s market position in the different medical equipment markets it operates in. The report provides Bausch & Lomb Incorporated market share information in four key market categories – Refractive Surgery Devices, Vitreo Retinal Surgery Devices, Cataract Surgery Devices and Vision Care. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets Bausch & Lomb Incorporated operates in – Ophthalmic Devices.
- Bausch & Lomb Incorporated’s company shares (in Revenues) information for all the key countries the company has presence in – Australia, India, Japan, China, Spain, Germany, Italy, United Kingdom, France, Canada, United States and Brazil.
- Bausch & Lomb Incorporated’s company shares (in Revenues) information for all the key market categories the company has presence in – Refractive Surgery Devices, Vitreo Retinal Surgery Devices, Cataract Surgery Devices and Vision Care.
- All the key data-points are for 2010 and cover all the key regions – Europe, North America, Asia-Pacific, Middle East and Africa and South and Central America.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in..
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Bausch & Lomb Incorporated operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Bausch & Lomb Incorporated’s market positions.

Table Of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of Markets/Categories Covered 14
3.1 Ophthalmic Devices 14
3.1.1 Cataract Surgery Devices 14
3.1.2 Glaucoma Surgery Devices 14
3.1.3 Refractive Surgery Devices 14
3.1.4 Vision Care 14
3.1.5 Vitreo Retinal Surgery Devices 14
4 Company Snapshot 15
4.1 Key Information 15
4.2 Company Overview 15
4.3 SWOT Snapshot 15
5 Business Description 16
5.1 Business Overview 16
5.2 Cataract and Vitreoretinal Surgery Product Category 16
5.2.1 Overview 16
5.2.2 Market View 16
5.3 Pharmaceuticals Category 16
5.3.1 Overview 16
5.4 Vision Care Product Category 17
5.4.1 Overview 17
5.4.2 Market View 17
5.5 Major Products and Services 18
5.5.1 Overview 18
6 History 19
7 SWOT Analysis 24
7.1 Overview 24
7.2 Bausch and Lomb Incorporated Strengths 24
7.2.1 Diversified Ophthalmic Devices Portfolio 24
7.2.2 Strong Brand Name 25
7.2.3 Widespread Geographical Presence 25
7.2.4 Strategic Collaborations 25
7.3 Bausch and Lomb Incorporated Weaknesses 25
7.3.1 Legal Proceedings 25
7.3.2 Product Call Backs 26
7.4 Bausch and Lomb Incorporated Opportunities 26
7.4.1 Product Launches 26
7.4.2 Growth in Ophthalmic Sector 26
7.4.3 Inorganic Growth Strategy 27
7.4.4 Growing Aged Population 27
7.4.5 Market Growth in Emerging Economies 27
7.5 Bausch and Lomb Incorporated Threats 28
7.5.1 Industry Consolidation Challenges 28
7.5.2 Stringent Government Regulations 28
7.5.3 Stiff Competition 28
8 Competitors 29
9 Competitive Landscape 30
9.1 Ophthalmic Devices, Global, Market Share (%), 2010 30
10 Bausch and Lomb Incorporated Medical Equipment Market Share Analysis 32
10.1 Bausch and Lomb Incorporated, Ophthalmic Devices, Global, Market Share (2010) 32
10.2 Bausch and Lomb Incorporated, Asia-Pacific, Market Share (2010) 33
10.3 Bausch and Lomb Incorporated, Europe, Market Share (2010) 34
10.4 Bausch and Lomb Incorporated, Middle East and Africa, Market Share (2010) 35
10.5 Bausch and Lomb Incorporated, North America, Market Share (2010) 36
10.6 Bausch and Lomb Incorporated, South and Central America, Market Share (2010) 37
11 Bausch and Lomb Incorporated Medical Equipment Market Share Analysis by Category 38
11.1 Bausch and Lomb Incorporated, Ophthalmic Devices, Global, Category Revenue Share (2010) 38
11.2 Bausch and Lomb Incorporated, Asia-Pacific, Category Revenue Share (2010) 40
11.2.1 Bausch and Lomb Incorporated, Australia, Category Revenue Share (2010) 42
11.2.2 Bausch and Lomb Incorporated, China, Category Revenue Share (2010) 44
11.2.3 Bausch and Lomb Incorporated, India, Category Revenue Share (2010) 46
11.2.4 Bausch and Lomb Incorporated, Japan, Category Revenue Share (2010) 48
11.2.5 Bausch and Lomb Incorporated, Other Asia-Pacific, Category Revenue Share (2010) 50
11.3 Bausch and Lomb Incorporated, Europe, Category Revenue Share (2010) 52
11.3.1 Bausch and Lomb Incorporated, France, Category Revenue Share (2010) 54
11.3.2 Bausch and Lomb Incorporated, Germany, Category Revenue Share (2010) 56
11.3.3 Bausch and Lomb Incorporated, Italy, Category Revenue Share (2010) 58
11.3.4 Bausch and Lomb Incorporated, Spain, Category Revenue Share (2010) 60
11.3.5 Bausch and Lomb Incorporated, United Kingdom, Category Revenue Share (2010) 62
11.3.6 Bausch and Lomb Incorporated, Other Europe, Category Revenue Share (2010) 64
11.4 Bausch and Lomb Incorporated, Middle East and Africa, Category Revenue Share (2010) 66
11.5 Bausch and Lomb Incorporated, North America, Category Revenue Share (2010) 68
11.5.1 Bausch and Lomb Incorporated, Canada, Category Revenue Share (2010) 70
11.5.2 Bausch and Lomb Incorporated, United States, Category Revenue Share (2010) 72
11.6 Bausch and Lomb Incorporated, South and Central America, Category Revenue Share (2010) 74
11.6.1 Bausch and Lomb Incorporated, Brazil, Category Revenue Share (2010) 76
11.6.2 Bausch and Lomb Incorporated, Other South and Central America, Category Revenue Share (2010) 78
12 Key Employees 80
13 Key Employee Biographies 82
14 Locations And Subsidiaries 84
14.1 Head Office 84
14.2 Other Locations and Subsidiaries 84
15 Financial Deals Landscape 87
15.1 Bausch and Lomb Incorporated, Deals Volume Summary, 2006 to YTD 2011 87
16 Bausch and Lomb Incorporated Detailed Deal Summary 89
16.1 Asset Purchase 89
16.1.1 Bausch and Lomb Acquires OTC Eye Care Products From Alimera 89
16.2 Venture Financing 90
16.2.1 eyeonics Secures $16.2 million In Series E Preferred Stock Financing 90
16.3 Private Equity 92
16.3.1 New York State Common Retirement Fund Invests $15 Million In Bausch and Lomb 92
16.3.2 Warburg Pincus Acquires Bausch and Lomb 93
16.4 Partnerships 95
16.4.1 Bausch and Lomb Enters Into Licensing Agreement With UltraVision 95
16.4.2 Bausch and Lomb Enters Into Agreement With Santen Pharmaceutical 96
16.4.3 Advanced Medical Optics Enters Into Licensing Agreement With Bausch and Lomb 97
16.4.4 CIBA Vision And Bausch and Lomb Enter Into Cross-License Agreement 98
16.4.5 Bausch and Lomb Enters Into Distribution Agreement With Technolas Perfect Vision 99
16.4.6 Bausch and Lomb Signs Joint Venture Agreement With 20/10 PERFECT VISION 100
16.4.7 Norwood EyeCare Signs An Agreement With Bausch and Lomb 101
16.5 Equity Offering 102
16.5.1 eyeonics Withdraws Its Initial Public Offering Of $86.25 Million 102
16.5.2 Bausch and Lomb Completes Private Placement Of Senior Notes Due 2015 For $650 Million 103
16.6 Acquisition 104
16.6.1 Bausch and Lomb To Acquire Technolas Perfect Vision From 20/10 PERFECT VISION 104
16.6.2 Bausch and Lomb Acquires eyeonics 105
16.6.3 AcuFocus Receives Investment From Bausch and Lomb 106
17 Recent Developments 107
17.1 Strategy And Business Planning 107
17.1.1 Jun 30, 2011: Bausch + Lomb Launches Pharmaceuticals Business In India 107
17.1.2 Dec 15, 2009: Bausch and Lomb Confirms Plans For Contact Lens Manufacturing Consolidation 107
17.1.3 Apr 29, 2009: Bausch and Lomb Plans To Market Surgical Equipment To Eye Doctors In Japan 108
17.1.4 Feb 02, 2009: Bausch and Lomb Plans To Expand In India 108
17.2 Financial Announcements 109
17.2.1 Aug 08, 2007: Bausch and Lomb Reports Q2 2007 Results 109
17.2.2 Jul 24, 2007: Bausch and Lomb Declares Quarterly Dividend 109
17.2.3 May 10, 2007: Bausch and Lomb Preliminary Q1 2007 Results 109
17.2.4 May 01, 2007: Bausch and Lomb Declares Quarterly Dividend 110
17.2.5 Mar 06, 2007: Bausch and Lomb Reports Preliminary Q4 And 2006 Results 110
17.2.6 Feb 26, 2007: Bausch and Lomb Declares Quarterly Dividend 111
17.2.7 Nov 09, 2006: Bausch and Lomb Reports Preliminary Q3 2006 Results 111
17.2.8 Nov 07, 2006: Bausch and Lomb Declares Quarterly Dividend 112
17.2.9 Jul 25, 2006: Bausch and Lomb Declares Quarterly Dividend 112
17.2.10 May 02, 2006: Bausch and Lomb Declares Quarterly Dividend 112
17.3 Research And Development 112
17.3.1 Jun 16, 2010: Bausch and Lomb And Lions Clubs Partner To Fight Childhood Blindness 112
17.4 Corporate Communications 113
17.4.1 Mar 24, 2011: Bausch + Lomb Appoints David Mordaunt As Vice President, Development And Research, Surgical 113
17.4.2 Mar 24, 2011: Bausch + Lomb Appoints David Mordaunt As Vice President, Development And Research, Surgical 113
17.4.3 Mar 18, 2011: Bausch + Lomb Appoints Calvin Roberts As Chief Medical Officer 114
17.4.4 Mar 18, 2011: Bausch + Lomb Appoints Calvin Roberts As Chief Medical Officer 115
17.4.5 Dec 21, 2010: Bausch + Lomb Appoints Rick Heinick As Corporate Vice President, Global Human Resources And Transformation 115
17.4.6 Nov 24, 2010: Bausch + Lomb Names Charl van Zyl As Commercial Leader Of EMEA 116
17.4.7 Nov 24, 2010: Bausch + Lomb Names Charl van Zyl As Commercial Leader, EMEA 116
17.4.8 Nov 04, 2010: Bausch + Lomb Announces Three New Appointments To Management Team 117
17.4.9 Oct 29, 2010: Bausch + Lomb Appoints Mariano García-Valiño As President, Latin America 117
17.4.10 Oct 29, 2010: Bausch + Lomb Appoints Mariano Garcia-Valino As President, Latin America 118
17.4.11 Sep 09, 2010: Bausch + Lomb Appoints Daniel Wechsler As Global President, Pharmaceuticals 118
17.4.12 Sep 02, 2010: Bausch + Lomb Appoints Michael Rowe As Corporate Vice President Of Human Resources 119
17.4.13 Jun 21, 2010: Bausch + Lomb Appoints Rodney Unsworth As President Of Asia-Pacific 119
17.4.14 Jun 20, 2010: Bausch + Lomb Names Rodney Unsworth As President, Asia-Pacific 120
17.4.15 Jun 16, 2010: Bausch + Lomb Appoints Robert Grant As CEO And President Of Surgical Business 120
17.4.16 Jun 16, 2010: Bausch + Lomb Appoints Robert Grant As CEO And President Of Surgical Business 121
17.4.17 May 28, 2010: Bausch + Lomb Appoints Hideyuki Ashikaga As President Of Japanese Operations 122
17.4.18 Mar 15, 2010: Bausch and Lomb Names Fred Hassan As Chairman, Brent Saunders As CEO 122
17.4.19 Mar 10, 2010: Bausch and Lomb Names Dr. Robert Steffen As Director Of Clinical Affairs, Vision Care 123
17.4.20 Dec 07, 2009: Bausch and Lomb Appoints Mohinder Merchea As Director Of Medical Affairs, North America, Vision Care 123
17.4.21 Nov 12, 2009: Bausch and Lomb Elects Fred Hassan To Its Board 124
17.4.22 Sep 23, 2009: Bausch and Lomb Appoints Kerry Clark And Robert Palmisano To Its Board 124
17.4.23 Jun 01, 2009: Bausch and Lomb Japan Appoints Francisco Ascencion As Its President 124
17.4.24 May 26, 2009: Bausch and Lomb Ireland Names Colum Honan As General Manager 125
17.4.25 May 11, 2009: Bausch and Lomb Appoints Peter Valenti Global Vision Care President And Steven F. Robins As North American Vision Care President 125
17.4.26 Apr 01, 2009: Bausch and Lomb Names Mitsuo Hirose As Chairman 126
17.4.27 Mar 25, 2009: Bausch and Lomb Names Brian J. Harris As CFO And Corporate Vice President 127
17.4.28 Mar 25, 2009: Bausch and Lomb Appoints Brian Harris As CFO And Corporate Vice President 127
17.4.29 Jan 16, 2009: Bausch and Lomb Appoints President, North America, Vision Care 128
17.5 Legal and Regulatory 128
17.5.1 May 31, 2009: Bausch and Lomb Settles $250 Million In Fungus Infection Lawsuits 128
17.5.2 Jun 20, 2008: Bausch and Lomb Sues Lexington Insurance 129
17.5.3 May 21, 2008: Bausch and Lomb Sued In St. Clair County 129
17.5.4 Aug 20, 2007: Bausch and Lomb And Alcon Settle Advertising Lawsuit 130
17.5.5 Jul 02, 2007: Bausch and Lomb Sued By Parker Waichman 130
17.5.6 Jun 26, 2007: Bausch and Lomb Files Suit Against Alcon 131
17.5.7 Nov 06, 2006: Bausch and Lomb Receives FDA Warning Letter Related To Inspection At Greenville 131
17.6 Government and Public Interest 132
17.6.1 Feb 24, 2011: Bausch + Lomb Conducts Voluntary Recall Of Soothe Xtra Protection Eye Drops 132
17.6.2 Jan 26, 2011: Bausch + Lomb Manufacturing Sites In Florida Achieve ISO 14001 And OHSAS 18001 Certifications For Environment, Health and Safety Management 132
17.6.3 Jul 22, 2010: Bausch + Lomb Voluntarily Recalls PreserVision Eye Vitamin AREDS 2 Formula In US 133
17.6.4 Jun 10, 2008: FDA Panel Recommends Stricter Contact Lens Labeling 133
17.7 Product News 134
17.7.1 Mar 23, 2011: Florence Henderson To Be Featured With Bausch + Lomb’s Crystalens At ASCRS 134
17.7.2 Mar 09, 2011: Bausch + Lomb Storz Ophthalmics Introduces E7002 Osher Sterile Field Magnifier 134
17.7.3 Feb 24, 2011: Bausch + Lomb Introduces Putterman Consecutive CDCR Set 135
17.7.4 Sep 29, 2010: Bausch + Lomb Storz Ophthalmic Instruments Launches Tru-Size Diamond Knife For Microincision Cataract Surgery 135
17.7.5 Sep 21, 2010: Bausch + Lomb Storz Ophthalmics Launches Whitman Double-Ended LRI Marker 135
17.7.6 Aug 31, 2010: Bausch + Lomb Releases Single-Use Vitreoretinal Asymmetric Peeling Forceps 136
17.7.7 Aug 23, 2010: Bausch + Lomb Introduces Stellaris PC Vision Enhancement System For Retinal Surgery 136
17.7.8 Aug 03, 2010: Bausch + Lomb Introduces Stellaris PC Vision Enhancement System 137
17.7.9 May 17, 2010: Bausch + Lomb Receives FDA Approval To Market Crystalens AO In Quarter Diopter Steps 137
17.7.10 Apr 15, 2010: Bausch + Lomb Receives NTIOL Classification From CMS For Crystalens AO 138
17.7.11 Apr 09, 2010: Bausch and Lomb To Celebrate Tenth Anniversary Of Crystalens At ASCRS Annual Meeting 138
17.7.12 Jan 04, 2010: Bausch and Lomb To Launch Crystalens Aspheric Optic (AO) Lens 138
17.7.13 Mar 03, 2009: Bausch and Lomb To Develop Intraocular Lens Using Santen’s Hydrophobic Acrylic Polymers 139
18 Appendix 140
18.1 Research Methodology 141
18.2 Secondary Research 141
18.3 Primary Research 142
18.4 Models 142
18.5 Forecasts 143
18.6 Expert Panels 143
18.7 GlobalData Consulting 143
18.8 Currency Conversion 144
18.9 Contact Us 145
18.10 Disclaimer 145

List of Tables

Table 1: Bausch and Lomb Incorporated, Key Facts, 2010 15
Table 2: Bausch and Lomb Incorporated, SWOT Analysis, 2010 24
Table 3: Ophthalmic Devices, Global, Company Share by Revenue ($m), 2010 31
Table 4: Bausch and Lomb Incorporated, Ophthalmic Devices, Global, Revenue ($m) and Market Share (%), 2010 32
Table 5: Bausch and Lomb Incorporated, Ophthalmic Devices, Asia-Pacific, Revenue ($m) and Market Share (%), 2010 33
Table 6: Bausch and Lomb Incorporated, Ophthalmic Devices, Europe, Revenue ($m) and Market Share (%), 2010 34
Table 7: Bausch and Lomb Incorporated, Ophthalmic Devices, Middle East and Africa, Revenue ($m) and Market Share (%), 2010 35
Table 8: Bausch and Lomb Incorporated, Ophthalmic Devices, North America, Revenue ($m) and Market Share (%), 2010 36
Table 9: Bausch and Lomb Incorporated, Ophthalmic Devices, South and Central America, Revenue ($m) and Market Share (%), 2010 37
Table 10: Bausch and Lomb Incorporated, Ophthalmic Devices, Global, Revenue ($m) and Market Share (%) by Category, 2010 39
Table 11: Bausch and Lomb Incorporated, Ophthalmic Devices, Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2010 41
Table 12: Bausch and Lomb Incorporated, Ophthalmic Devices, Australia, Revenue ($m) and Market Share (%) by Category, 2010 43
Table 13: Bausch and Lomb Incorporated, Ophthalmic Devices, China, Revenue ($m) and Market Share (%) by Category, 2010 45
Table 14: Bausch and Lomb Incorporated, Ophthalmic Devices, India, Revenue ($m) and Market Share (%) by Category, 2010 47
Table 15: Bausch and Lomb Incorporated, Ophthalmic Devices, Japan, Revenue ($m) and Market Share (%) by Category, 2010 49
Table 16: Bausch and Lomb Incorporated, Ophthalmic Devices, Other Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2010 51
Table 17: Bausch and Lomb Incorporated, Ophthalmic Devices, Europe, Revenue ($m) and Market Share (%) by Category, 2010 53
Table 18: Bausch and Lomb Incorporated, Ophthalmic Devices, France, Revenue ($m) and Market Share (%) by Category, 2010 55
Table 19: Bausch and Lomb Incorporated, Ophthalmic Devices, Germany, Revenue ($m) and Market Share (%) by Category, 2010 57
Table 20: Bausch and Lomb Incorporated, Ophthalmic Devices, Italy, Revenue ($m) and Market Share (%) by Category, 2010 59
Table 21: Bausch and Lomb Incorporated, Ophthalmic Devices, Spain, Revenue ($m) and Market Share (%) by Category, 2010 61
Table 22: Bausch and Lomb Incorporated, Ophthalmic Devices, United Kingdom, Revenue ($m) and Market Share (%) by Category, 2010 63
Table 23: Bausch and Lomb Incorporated, Ophthalmic Devices, Other Europe, Revenue ($m) and Market Share (%) by Category, 2010 65
Table 24: Bausch and Lomb Incorporated, Ophthalmic Devices, Middle East and Africa, Revenue ($m) and Market Share (%) by Category, 2010 67
Table 25: Bausch and Lomb Incorporated, Ophthalmic Devices, North America, Revenue ($m) and Market Share (%) by Category, 2010 69
Table 26: Bausch and Lomb Incorporated, Ophthalmic Devices, Canada, Revenue ($m) and Market Share (%) by Category, 2010 71
Table 27: Bausch and Lomb Incorporated, Ophthalmic Devices, United States, Revenue ($m) and Market Share (%) by Category, 2010 73
Table 28: Bausch and Lomb Incorporated, Ophthalmic Devices, South and Central America, Revenue ($m) and Market Share (%) by Category, 2010 75
Table 29: Bausch and Lomb Incorporated, Ophthalmic Devices, Brazil, Revenue ($m) and Market Share (%) by Category, 2010 77
Table 30: Bausch and Lomb Incorporated, Ophthalmic Devices, Other South and Central America, Revenue ($m) and Market Share (%) by Category, 2010 79
Table 31: Bausch and Lomb Incorporated, Key Employees 80
Table 32: Bausch and Lomb Incorporated, Other Locations 84
Table 33: Bausch and Lomb Incorporated, Subsidiaries 85
Table 34: Bausch and Lomb Incorporated, Deals Volume Summary, 2006 to YTD 2011 87
Table 35: Bausch and Lomb Incorporated, Deals Summary, 2006 to YTD 2011 88
Table 36: Bausch and Lomb Acquires OTC Eye Care Products From Alimera 89
Table 37: eyeonics Secures $16.2 million In Series E Preferred Stock Financing 90
Table 38: New York State Common Retirement Fund Invests $15 Million In Bausch and Lomb 92
Table 39: Warburg Pincus Acquires Bausch and Lomb 93
Table 40: Bausch and Lomb Enters Into Licensing Agreement With UltraVision 95
Table 41: Bausch and Lomb Enters Into Agreement With Santen Pharmaceutical 96
Table 42: Advanced Medical Optics Enters Into Licensing Agreement With Bausch and Lomb 97
Table 43: CIBA Vision And Bausch and Lomb Enter Into Cross-License Agreement 98
Table 44: Bausch and Lomb Enters Into Distribution Agreement With Technolas Perfect Vision 99
Table 45: Bausch and Lomb Signs Joint Venture Agreement With 20/10 PERFECT VISION 100
Table 46: Norwood EyeCare Signs An Agreement With Bausch and Lomb 101
Table 47: eyeonics Withdraws Its Initial Public Offering Of $86.25 Million 102
Table 48: Bausch and Lomb Completes Private Placement Of Senior Notes Due 2015 For $650 Million 103
Table 49: Bausch and Lomb To Acquire Technolas Perfect Vision From 20/10 PERFECT VISION 104
Table 50: Bausch and Lomb Acquires eyeonics 105
Table 51: AcuFocus Receives Investment From Bausch and Lomb 106
Table 52: USD to Local Currency, Average Exchange Rate, 2010 144

List of Figures

Figure 1: Ophthalmic Devices, Global, Market Share (%), 2010 30
Figure 2: Bausch and Lomb Incorporated, Ophthalmic Devices, Global, Market Share (%), 2010 32
Figure 3: Bausch and Lomb Incorporated, Ophthalmic Devices, Asia-Pacific, Market Share (%), 2010 33
Figure 4: Bausch and Lomb Incorporated, Ophthalmic Devices, Europe, Market Share (%), 2010 34
Figure 5: Bausch and Lomb Incorporated, Ophthalmic Devices, North America, Market Share (%), 2010 36
Figure 6: Bausch and Lomb Incorporated, Ophthalmic Devices, South and Central America, Market Share (%), 2010 37
Figure 7: Bausch and Lomb Incorporated, Ophthalmic Devices, Global, Category Revenue Share (%), 2010 38
Figure 8: Bausch and Lomb Incorporated, Ophthalmic Devices, Global, Market Share (%) by Category, 2010 39
Figure 9: Bausch and Lomb Incorporated, Ophthalmic Devices, Asia-Pacific, Category Revenue Share (%), 2010 40
Figure 10: Bausch and Lomb Incorporated, Ophthalmic Devices, Asia-Pacific, Market Share (%) by Category, 2010 41
Figure 11: Bausch and Lomb Incorporated, Ophthalmic Devices, Australia, Category Revenue Share (%), 2010 42
Figure 12: Bausch and Lomb Incorporated, Ophthalmic Devices, Australia, Market Share (%) by Category, 2010 43
Figure 13: Bausch and Lomb Incorporated, Ophthalmic Devices, China, Category Revenue Share (%), 2010 44
Figure 14: Bausch and Lomb Incorporated, Ophthalmic Devices, China, Market Share (%) by Category, 2010 45
Figure 15: Bausch and Lomb Incorporated, Ophthalmic Devices, India, Category Revenue Share (%), 2010 46
Figure 16: Bausch and Lomb Incorporated, Ophthalmic Devices, India, Market Share (%) by Category, 2010 47
Figure 17: Bausch and Lomb Incorporated, Ophthalmic Devices, Japan, Category Revenue Share (%), 2010 48
Figure 18: Bausch and Lomb Incorporated, Ophthalmic Devices, Japan, Market Share (%) by Category, 2010 49
Figure 19: Bausch and Lomb Incorporated, Ophthalmic Devices, Other Asia-Pacific, Category Revenue Share (%), 2010 50
Figure 20: Bausch and Lomb Incorporated, Ophthalmic Devices, Other Asia-Pacific, Market Share (%) by Category, 2010 51
Figure 21: Bausch and Lomb Incorporated, Ophthalmic Devices, Europe, Category Revenue Share (%), 2010 52
Figure 22: Bausch and Lomb Incorporated, Ophthalmic Devices, Europe, Market Share (%) by Category, 2010 53
Figure 23: Bausch and Lomb Incorporated, Ophthalmic Devices, France, Category Revenue Share (%), 2010 54
Figure 24: Bausch and Lomb Incorporated, Ophthalmic Devices, France, Market Share (%) by Category, 2010 55
Figure 25: Bausch and Lomb Incorporated, Ophthalmic Devices, Germany, Category Revenue Share (%), 2010 56
Figure 26: Bausch and Lomb Incorporated, Ophthalmic Devices, Germany, Market Share (%) by Category, 2010 57
Figure 27: Bausch and Lomb Incorporated, Ophthalmic Devices, Italy, Category Revenue Share (%), 2010 58
Figure 28: Bausch and Lomb Incorporated, Ophthalmic Devices, Italy, Market Share (%) by Category, 2010 59
Figure 29: Bausch and Lomb Incorporated, Ophthalmic Devices, Spain, Category Revenue Share (%), 2010 60
Figure 30: Bausch and Lomb Incorporated, Ophthalmic Devices, Spain, Market Share (%) by Category, 2010 61
Figure 31: Bausch and Lomb Incorporated, Ophthalmic Devices, United Kingdom, Category Revenue Share (%), 2010 62
Figure 32: Bausch and Lomb Incorporated, Ophthalmic Devices, United Kingdom, Market Share (%) by Category, 2010 63
Figure 33: Bausch and Lomb Incorporated, Ophthalmic Devices, Other Europe, Category Revenue Share (%), 2010 64
Figure 34: Bausch and Lomb Incorporated, Ophthalmic Devices, Other Europe, Market Share (%) by Category, 2010 65
Figure 35: Bausch and Lomb Incorporated, Ophthalmic Devices, Middle East and Africa, Category Revenue Share (%), 2010 66
Figure 36: Bausch and Lomb Incorporated, Ophthalmic Devices, Middle East and Africa, Market Share (%) by Category, 2010 67
Figure 37: Bausch and Lomb Incorporated, Ophthalmic Devices, North America, Category Revenue Share (%), 2010 68
Figure 38: Bausch and Lomb Incorporated, Ophthalmic Devices, North America, Market Share (%) by Category, 2010 69
Figure 39: Bausch and Lomb Incorporated, Ophthalmic Devices, Canada, Category Revenue Share (%), 2010 70
Figure 40: Bausch and Lomb Incorporated, Ophthalmic Devices, Canada, Market Share (%) by Category, 2010 71
Figure 41: Bausch and Lomb Incorporated, Ophthalmic Devices, United States, Category Revenue Share (%), 2010 72
Figure 42: Bausch and Lomb Incorporated, Ophthalmic Devices, United States, Market Share (%) by Category, 2010 73
Figure 43: Bausch and Lomb Incorporated, Ophthalmic Devices, South and Central America, Category Revenue Share (%), 2010 74
Figure 44: Bausch and Lomb Incorporated, Ophthalmic Devices, South and Central America, Market Share (%) by Category, 2010 75
Figure 45: Bausch and Lomb Incorporated, Ophthalmic Devices, Brazil, Category Revenue Share (%), 2010 76
Figure 46: Bausch and Lomb Incorporated, Ophthalmic Devices, Brazil, Market Share (%) by Category, 2010 77
Figure 47: Bausch and Lomb Incorporated, Ophthalmic Devices, Other South and Central America, Category Revenue Share (%), 2010 78
Figure 48: Bausch and Lomb Incorporated, Ophthalmic Devices, Other South and Central America, Market Share (%) by Category, 2010 79
Figure 49: Bausch and Lomb Incorporated, Deals Volume Summary, 2006 to YTD 2011 87

Companies Mentioned

Abbott Medical Optics, Inc.
Alcon, Inc.
Carl Zeiss AG
CIBA Vision Corporation
Cooper Vision, Inc.
Essilor International
HOYA Corporation
Johnson and Johnson Vision Care, Inc.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Rohto Pharmaceutical Co., Ltd. (4527) - Financial and Strategic SWOT Analysis Review

Rohto Pharmaceutical Co., Ltd. (4527) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

Summary ROHTO Pharmaceutical Co.,Ltd. (ROHTO Pharmaceutical) is a pharmaceutical company. The company manufactures and markets eye care and skin care products, cosmetics, functional foods, other internal ...

Sun Hing Vision Group Holdings Ltd. (Symbol:0125) SWOT Analysis, Strategy, Revenues and Profits

Sun Hing Vision Group Holdings Ltd. (Symbol:0125) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Eyecare Partners Limited - Financial and Strategic SWOT Analysis Review

Eyecare Partners Limited - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

Summary This comprehensive SWOT profile of Eyecare Partners Limited provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.